NCT05969405

Brief Summary

Objective：To compare the clinical outcomes of endometrial cancer patients who received surgerical treatments: Comparisons of robotic-assisted laparoscopic, laparoscopic and laparotomic methods

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
400

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 7, 2023

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

July 23, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

August 1, 2023

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

August 1, 2023

Status Verified

July 1, 2023

Enrollment Period

1.5 years

First QC Date

July 23, 2023

Last Update Submit

July 23, 2023

Conditions

Endometrial Cancer

Outcome Measures

Primary Outcomes (1)

  • Overall survival

    Overall survival

    5 years

Secondary Outcomes (5)

  • Progression free survival

    5 years

  • length of hospital stay

    2 weeks

  • surgical time

    1 day

  • Estimate blood loss

    1 day

  • lymph node number

    1 day

Study Arms (3)

Laparoscopy

Laparoscopic staging group

Procedure: Laparoscopic staging

Robotic

Robotic staing group

Procedure: Robotic staging

Laparotomic

Laparotomic group

Procedure: Laparotomic staging

Interventions

Laparoscopic stagingPROCEDURE

Laparoscopic staging

Laparoscopy
Robotic stagingPROCEDURE

Robotic staging

Robotic
Laparotomic stagingPROCEDURE

Laparotomic staging

Laparotomic

Eligibility Criteria

Age20 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsWomen with endometrial cancer who were treated in Far Eastern Memorial Hospital from January 01, 2008 to November 30, 2022 were be reviewed.
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

endometrial cancer patients

You may qualify if:

  • womwn who received endometrial cancer surgical from January 01, 2008 to November 30, 2022 were be reviewed.

You may not qualify if:

  • Endometrial cancer patients did not undergo surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital

Banqiao District, New Taipei, 22050, Taiwan

RECRUITING

MeSH Terms

Conditions

Endometrial Neoplasms

Condition Hierarchy (Ancestors)

Uterine NeoplasmsGenital Neoplasms, FemaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief, Department of Obstetrics & Gynecology

Study Record Dates

First Submitted

July 23, 2023

First Posted

August 1, 2023

Study Start

July 7, 2023

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

August 1, 2023

Record last verified: 2023-07

Locations

TW(1)